Cleveland boasts stem cell research hub

While Massachusetts and California have been gaining wide recognition for cutting-edge scientific work in the stem cell field, Cleveland has been quietly building up its own reputation in the burgeoning new industry. The Plain Dealer makes the case that the Center for Stem Cell and Regenerative Medicine has been able to leverage state funding to help launch a string of biotech start-ups. Report

Suggested Articles

With a new research team, outlook and more than a little help from the tech world, GSK has been quietly going about shoring up its pipeline.

The World Health Organization has called out Big Pharma for its dearth of antibiotic innovation amid a growing threat of antimicrobial resistance.

The trial hit its primary endpoint by the time of an interim analysis, enabling Chi-Med to stop the study and start work on a filing for approval.